
YK-11
August 15, 2024
GW501516 (Cardarine) (30ml)
November 15, 2024AC-262 is a lesser-known but promising SARM that was developed for its muscle-building and bone density enhancing effects without the unwanted side effects associated with traditional anabolic steroids. This SARM is particularly interesting for its low impact on androgen receptors in the prostate, making it less likely to cause unwanted side effects like prostatic hypertrophy or testosterone suppression.
One of the key features of AC-262 is its ability to stimulate muscle growth in a moderate manner while having a relatively favorable safety profile. While not as potent as other SARMs like RAD-140 or LGD-4033 in terms of muscle gain, AC-262 stands out for its potential to promote improvements in strength and bone density without causing water retention or estrogenic effects.
Another key benefit of AC-262 is its low impact on natural testosterone production. Studies indicate that this SARM causes minimal suppression of LH (luteinizing hormone) and FSH (follicle-stimulating hormone) production, reducing the risk of significant hormonal suppression.
*Side effects reported in studies:*
1. Mild impact on the prostate
2. Minimal suppression of testosterone (LH and FSH) production
3. Potential lipid profile changes
4. Mild headaches
5. Mild loss of libido
*Rating:*
– Mass gain: 3/5
– Fat loss: 2.5/5
– Strength gain: 3.25/5
– Safety profile: 4/5
*Average: 3.19/5*
| Size | 20mg, 30mg |
|---|


Reviews
There are no reviews yet.